Nevertheless, growth stocks outperformed value stocks in 2024, and investors anticipate that trend will continue as the ...

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Iranian businessman Mohammad Abedini was released after an Italian journalist was freed by Tehran.

Booz Allen (BAH) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck. But what's the best way ...

Learn more about Zhengye Biotechnology Holding Limited's (ZYBT) stock grades for Value and determine whether this Pharmaceuticals stock meets your investment needs.

Enhance portfolio yield by selling options on precious metals ETFs, leveraging high implied volatility. Click here for a ...

WBA's fiscal 2025 first-quarter results are expected to continue to reflect a soft U.S. Retail Pharmacy performance.

Foreign investors keep net-purchasing streak despite disappointment over chip stocks Korean shares gained on Tuesday with the ...

Learn more about Pursuit Attractions and Hospitality, Inc.'s (PRSU) stock grades for Value, Momentum, Growth and Estimate Revisions and determine whether this Commercial Services & Supplies stock ...

The average brokerage recommendation (ABR) for Citigroup (C) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after ...